# **Clinical Logic Collection Template**

**Purpose:** Collect rich, clinically validated knowledge to generate realistic synthetic patient data.

---

## **SECTION 1: DISEASE OVERVIEW**

| Field | Description / Notes | Response |
| ----- | ----- | ----- |
| Disease Name (Clinical) |  |  |
| Common / Layman Term |  |  |
| Disease Type | ‚òê Acute ‚òê Chronic ‚òê Recurrent ‚òê Congenital |  |
| Typical Age of Onset |  |  |
| Gender Prevalence | ‚òê Male ‚òê Female ‚òê Equal ‚òê Context-dependent |  |
| Rural/Urban Differences |  |  |

---

## **SECTION 2: DISEASE SUBTYPES / CLASSIFICATIONS**

| Subtype Name | Diagnostic Criteria / Features | Distinct Treatment? (Y/N) | Nots |
| ----- | ----- | ----- | ----- |
|  |  |  |  |

---

## **SECTION 3: FAMILY HISTORY & GENETIC RISK**

| Risk Factor / Trait | Inheritance Pattern (e.g. polygenic, autosomal) | Influence on Onset/Severity |
| ----- | ----- | ----- |
|  |  |  |

---

## **SECTION 4: CLINICAL STAGING**

| Stage Name | Diagnostic Criteria (labs, vitals, clinical signs) | Approx. Duration | Transition Triggers / Notes |
| ----- | ----- | ----- | ----- |
| Stage 1 (Early) |  |  |  |
| Stage 2 (Moderate) |  |  |  |
| Stage 3 (Severe) |  |  |  |

---

## **SECTION 5: SYMPTOMS BY STAGE**

| Stage | Major (Typical) Symptoms | Early/Hidden Symptoms | Symptom Prevalence (%) |
| ----- | ----- | ----- | ----- |
| Early |  |  |  |
| Moderate |  |  |  |
| Advanced |  |  |  |

---

## **SECTION 6: COMMON COMORBIDITIES**

| Comorbidity | Frequency (%) | Common Onset Stage | Complicates Treatment? (Y/N) | Notes |
| ----- | ----- | ----- | ----- | ----- |
|  |  |  |  |  |

---

## **SECTION 7: MEDICATION PROTOCOL**

| Stage | Line of Treatment | Drug Class / Generic Name | Standard Dosage | Trigger to Start/Stop | Notes (e.g., side effects, cost) |
| ----- | ----- | ----- | ----- | ----- | ----- |
| Early |  |  |  |  |  |
| Moderate |  |  |  |  |  |
| Advanced |  |  |  |  |  |

---

## **SECTION 8: RED FLAGS & EMERGENCY CONDITIONS**

| Symptom / Event | Stage When Appears | Hospitalization Required (Y/N) | Critical Action Required |
| ----- | ----- | ----- | ----- |
|  |  |  |  |

---

## **SECTION 9: DISEASE PROGRESSION TIMELINE**

| Stage | Average Duration (weeks/months/years) | Triggers for Progression |
| ----- | ----- | ----- |
| Early |  |  |
| Moderate |  |  |
| Advanced |  |  |

---

## **üèÉ‚Äç‚ôÇÔ∏è SECTION 10: LIFESTYLE MANAGEMENT GUIDANCE**

| Intervention Type | Description | Recommended Stage(s) | Notes |
| ----- | ----- | ----- | ----- |
| Diet |  |  |  |
| Exercise |  |  |  |
| Other |  |  |  |

---

## **SECTION 11: PEDIATRIC VS. ADULT PRESENTATION**

| Age Group | Unique Features / Differences |
| ----- | ----- |
| Pediatric |  |
| Adult |  |

---

## **SECTION 12: LAB VALUE RANGES BY STAGE**

| Stage | Lab Name | Expected Range | Critical Values / Units | Notes |
| ----- | ----- | ----- | ----- | ----- |
| Early |  |  |  |  |
| Moderate |  |  |  |  |
| Advanced |  |  |  |  |

---

## **SECTION 13: CONTRAINDICATIONS & TREATMENT CONFLICTS**

| Drug / Procedure | Contraindicated In (Condition/State) | Notes |
| ----- | ----- | ----- |
|  |  |  |

---

## **SECTION 14: MONITORING & FOLLOW-UP REQUIREMENTS**

| Stage | Follow-up Frequency | Key Metrics to Monitor |
| ----- | ----- | ----- |
| Early |  |  |
| Moderate |  |  |
| Advanced |  |  |

---

## **SECTION 15: COMMON MISDIAGNOSES / DIFFERENTIAL DIAGNOSES**

| Often Misdiagnosed As | Key Differentiators / Tests | Notes |
| ----- | ----- | ----- |
|  |  |  |

---

## **SECTION 16: REGIONAL PRACTICES & VARIATIONS**

| Factor | Urban Practice | Rural Practice |
| ----- | ----- | ----- |
| Diagnosis Methods |  |  |
| Medication Use |  |  |
| Patient Behavior |  |  |

---

## **SECTION 17: ADDITIONAL NOTES**

* Cultural aspects influencing symptom reporting  
* Socioeconomic barriers affecting treatment adherence  
* Any other relevant observations

---

## **SECTION 18: PHYSICIAN CONSENT & ATTRIBUTION**

| Field | Response |
| ----- | ----- |
| Name / Role |  |
| Institution |  |
| Consent for Acknowledgment | ‚òê Yes ‚òê No |
| Consent to Use Data in Research | ‚òê Yes ‚òê No |
| Date |  |

---

## **Submission Checklist**

- [ ] All stages have diagnostic and symptom data  
- [ ] Medication protocols are detailed per stage  
- [ ] Red flags and emergency triggers are clear  
- [ ] Comorbidities and genetic risk factors included  
- [ ] Monitoring and progression timelines are documented  
- [ ] Regional/cultural variations noted

